Viridian Therapeutics, Inc.\DE short interest in 2025
In 2025, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 14.69% of shares outstanding on 15 Jan 2025 to 9.10% on 31 Dec 2025, a change of -5.59 percentage points. The year's high was 14.69% on 15 Jan 2025 and its low 9.10% on 31 Dec 2025, averaging 12.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.65 days on 31 Jul 2025. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 14.69% (15 Jan 2025)
- End of year
- 9.10% (31 Dec 2025)
- Change
- -5.59 pp
- High
- 14.69% (15 Jan 2025)
- Low
- 9.10% (31 Dec 2025)
- Average
- 12.58%
- Highest days to cover
- 18.65 (31 Jul 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 14.69% | 7.29 | |
| 31 Jan 2025 | 13.74% | 11.77 | |
| 14 Feb 2025 | 12.30% | 9.58 | |
| 28 Feb 2025 | 12.08% | 10.76 | results (8-K) |
| 14 Mar 2025 | 12.62% | 12.05 | 10-K filed |
| 31 Mar 2025 | 12.83% | 13.33 | |
| 15 Apr 2025 | 13.94% | 8.59 | |
| 30 Apr 2025 | 12.78% | 13.08 | |
| 15 May 2025 | 12.93% | 12.77 | 10-Q filed, results (8-K) |
| 30 May 2025 | 13.12% | 13.22 | |
| 13 Jun 2025 | 13.89% | 15.94 | |
| 30 Jun 2025 | 13.21% | 14.47 | |
| 15 Jul 2025 | 14.27% | 15.54 | |
| 31 Jul 2025 | 14.31% | 18.65 | |
| 15 Aug 2025 | 14.43% | 14.01 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.17% | 13.64 | |
| 15 Sep 2025 | 13.47% | 12.33 | |
| 30 Sep 2025 | 12.53% | 15.95 | |
| 15 Oct 2025 | 12.23% | 11.76 | |
| 31 Oct 2025 | 10.23% | 5.35 | results (8-K) |
| 14 Nov 2025 | 9.92% | 4.60 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.61% | 5.03 | |
| 15 Dec 2025 | 9.47% | 6.49 | |
| 31 Dec 2025 | 9.10% | 6.04 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.